Structures of langya virus fusion protein ectodomain and immunogenic compositions derived therefrom
US-2024358817-A1 · Oct 31, 2024 · US
Combination vaccine for respiratory syncytial virus and influenza
US2016000902A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016000902-A1 |
| Application number | US-201414767247-A |
| Country | US |
| Kind code | A1 |
| Filing date | Feb 11, 2014 |
| Priority date | Jul 11, 2003 |
| Publication date | Jan 7, 2016 |
| Grant date | — |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present disclosure is directed to compositions and methods for raising immune responses against influenza and respiratory syncytial virus by administering combination immunogenic composition against both viruses at the same time. The combination compositions contain an RSV component and one, two, three, four, or more influenza components. The combination compositions provide a greater immune response than that obtained by separately administering the RSV and influenza components.
First claim
Opening claim text (preview).
1 . An immunogenic composition comprising a respiratory syncytial virus (RSV) fusion (F) component and an influenza component. 2 . The composition of claim 1 wherein the RSV F component comprises an RSV F protein. 3 . The composition of claim 1 wherein the influenza component comprises an influenza Virus-Like Particle (VLP). 4 . The composition of claim 3 wherein the influenza VLP comprises an influenza HA protein, an influe…
Assignees
Inventors
Classifications
- A61K39/155Primary
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US2016000902A1 cover?
- The present disclosure is directed to compositions and methods for raising immune responses against influenza and respiratory syncytial virus by administering combination immunogenic composition against both viruses at the same time. The combination compositions contain an RSV component and one, two, three, four, or more influenza components. The combination compositions provide a greater immun…
- Who is the assignee on this patent?
- Novavax Inc
- What technology area does this patent fall under?
- Primary CPC classification A61K39/155. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Thu Jan 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).